First Trust NYSE Arca Biotechnology Index Fund Rating $174.32 +2.37 (+1.38%) As of 08/15/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy 2.64Holdings in FBT have an aggregate rating of Moderate Buy based on 454 analyst ratings issued in the past year covering 25 companies (85.9% of the portfolio).FBT Aggregate Price Target$174.32High Prediction$174.32Average Prediction$174.32Low Prediction$174.32Holdings in FBT have an aggregate price target of $174.32 and a range of $174.32 to $174.32 covering 25 companies (85.9% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FBT Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.91%ONCBeOne Medicines$321.36+3.8%0.649 of 5 stars3.00$330.89 3.0%7Insider Trade3.72%ACADACADIA Pharmaceuticals$25.33+3.3%3.9112 of 5 stars2.61$28.88 14.0%18News CoverageAnalyst Upgrade3.70%ILMNIllumina$100.11+0.0%4.5896 of 5 stars2.25$124.58 24.4%20News CoveragePositive NewsAnalyst Downgrade3.67%GMABGenmab A/S$23.31+1.4%3.9893 of 5 stars2.64$37.60 61.3%11Positive NewsAnalyst ForecastAnalyst Revision3.56%GILDGilead Sciences$118.37-0.5%4.8746 of 5 stars2.80$114.82 -3.0%25Positive NewsAnalyst Revision3.55%ARGXargenex$653.83+0.2%3.9625 of 5 stars3.10$746.81 14.2%20Positive News3.51%ALNYAlnylam Pharmaceuticals$448.91+1.4%4.243 of 5 stars2.85$405.33 -9.7%26Positive NewsInsider Trade3.49%AMGNAmgen$296.47+2.1%4.6652 of 5 stars2.33$303.76 2.5%21Trending NewsAnalyst Revision3.47%MTDMettler-Toledo International$1,315.67+0.2%3.9963 of 5 stars2.50$1,288.89 -2.0%10News CoveragePositive NewsInsider Trade3.46%UTHRUnited Therapeutics$313.13+0.3%4.9133 of 5 stars2.69$382.00 22.0%13Positive NewsAnalyst Forecast3.44%INCYIncyte$86.92+0.9%4.6519 of 5 stars2.33$81.20 -6.6%18Trending News3.43%BNTXBioNTech$113.52+0.7%1.7724 of 5 stars2.76$135.80 19.6%17News CoverageAnalyst ForecastAnalyst Revision3.42%HALOHalozyme Therapeutics$67.27+2.6%4.6673 of 5 stars2.18$66.56 -1.1%11Positive NewsInsider Trade3.41%BMRNBioMarin Pharmaceutical$57.54-0.8%4.9979 of 5 stars2.75$93.17 61.9%24Positive News3.41%EXELExelixis$38.31-0.4%4.8717 of 5 stars2.55$44.06 15.0%22Positive NewsAnalyst Forecast3.41%MRNAModerna$28.02+5.0%4.3922 of 5 stars2.04$43.59 55.6%24Options Volume3.36%VRTXVertex Pharmaceuticals$392.79+0.6%4.9493 of 5 stars2.56$497.10 26.6%27Positive News3.34%KRYSKrystal Biotech$150.270.0%4.6688 of 5 stars3.00$210.75 40.2%9Positive News3.33%REGNRegeneron Pharmaceuticals$580.41+2.6%4.8322 of 5 stars2.81$829.65 42.9%26News CoveragePositive NewsDividend AnnouncementAnalyst ForecastAnalyst RevisionGap Up3.32%NBIXNeurocrine Biosciences$132.90+1.2%4.8463 of 5 stars2.86$160.90 21.1%22Positive News3.29%BIIBBiogen$138.60+2.7%4.8569 of 5 stars2.34$185.74 34.0%32Positive NewsAnalyst ForecastAnalyst Revision3.22%BRKRBruker$33.52-0.4%4.9633 of 5 stars2.45$51.30 53.0%11Dividend AnnouncementGap Up3.19%CORTCorcept Therapeutics$71.75-0.3%4.7144 of 5 stars3.00$134.50 87.5%5News CoveragePositive NewsInsider Trade3.14%EXASExact Sciences$45.60+1.4%4.8794 of 5 stars2.92$67.43 47.9%24News CoverageAnalyst Forecast3.14%RGENRepligen$124.35-1.8%4.8407 of 5 stars2.73$169.45 36.3%11News CoveragePositive NewsInsider Trade This page (NYSEARCA:FBT) was last updated on 8/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access